We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 11, 2021

New and Emerging Therapies for Reduction of LDL Cholesterol and Apolipoprotein B

JACC: Journal of the American College of Cardiology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Journal of the American College of Cardiology
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4
J Am Coll Cardiol 2021 Mar 30;77(12)1564-1575, NS Nurmohamed, AM Navar, JJP Kastelein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading